Literature DB >> 10952971

Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum.

Y Shakur1, K Takeda, Y Kenan, Z X Yu, G Rena, D Brandt, M D Houslay, E Degerman, V J Ferrans, V C Manganiello.   

Abstract

Subcellular localization of cyclic nucleotide phosphodiesterases (PDEs) may be important in compartmentalization of cAMP/cGMP signaling responses. In 3T3-L1 adipocytes, mouse (M) PDE3B was associated with the endoplasmic reticulum (ER) as indicated by its immunofluorescent colocalization with the ER protein BiP and subcellular fractionation studies. In transfected NIH 3006 or COS-7 cells, recombinant wild-type PDE3A and PDE3B isoforms were both found almost exclusively in the ER. The N-terminal portion of PDE3 can be arbitrarily divided into region 1 (aa 1-300), which contains a large hydrophobic domain with six predicted transmembrane helices, followed by region 2 (aa 301-500) containing a smaller hydrophobic domain (of approximately 50 aa). To investigate the role of regions 1 and 2 in membrane association, we examined the subcellular localization of a series of catalytically active, Flag-tagged N-terminal-truncated human (H) PDE3A and MPDE3B recombinants, as well as a series of fragments from regions 1 and 2 of MPDE3B synthesized as enhanced green fluorescent (EGFP) fusion proteins in COS-7 cells. In COS-7 cells, the localization of a mutant HPDE3A, lacking the first 189 amino acids (aa) and therefore four of the six predicted transmembrane helices (H3A-Delta189), was virtually identical to that of the wild type. M3B-Delta302 (lacking region 1) and H3A-Delta397 (lacking region 1 as well as part of region 2) retained, to different degrees, the ability to associate with membranes, albeit less efficiently than H3A-Delta189. Proteins that lacked both regions 1 and 2, H3A-Delta510 and M3B-Delta604, did not associate with membranes. Consistent with these findings, region 1 EGFP-MPDE3B fusion proteins colocalized with the ER, whereas region 2 EGFP fusion proteins were diffusely distributed. Thus, some portion of the N-terminal hydrophobic domain in region 1 plus a second domain in region 2 are important for efficient membrane association/targeting of PDE3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952971     DOI: 10.1074/jbc.M001734200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 2.  From PDE3B to the regulation of energy homeostasis.

Authors:  Eva Degerman; Faiyaz Ahmad; Youn Wook Chung; Emilia Guirguis; Bilal Omar; Lena Stenson; Vincent Manganiello
Journal:  Curr Opin Pharmacol       Date:  2011-10-14       Impact factor: 5.547

Review 3.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

4.  Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428.

Authors:  Mercedes Pozuelo Rubio; David G Campbell; Nicholas A Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

5.  Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12.

Authors:  Xiaoyun Wu; Gavin R Schnitzler; Galen F Gao; Brett Diamond; Andrew R Baker; Bethany Kaplan; Kaylyn Williamson; Lindsay Westlake; Selena Lorrey; Timothy A Lewis; Colin W Garvie; Martin Lange; Sikander Hayat; Henrik Seidel; John Doench; Andrew D Cherniack; Charlotte Kopitz; Matthew Meyerson; Heidi Greulich
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

6.  Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi.

Authors:  Maximiliano A D'Angelo; Santiago Sanguineti; Jeffrey M Reece; Lutz Birnbaumer; Héctor N Torres; Mirtha M Flawiá
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 7.  Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.

Authors:  Satish Cheepala; Jean-Sebastien Hulot; Jessica A Morgan; Yassine Sassi; Weiqiang Zhang; Anjaparavanda P Naren; John D Schuetz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-16       Impact factor: 13.820

8.  Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Meera Sridharan; Shaquria Adderley; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

9.  Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases.

Authors:  Alessandra Ghigo; Alessia Perino; Hind Mehel; Alexandra Zahradníková; Fulvio Morello; Jérôme Leroy; Viacheslav O Nikolaev; Federico Damilano; James Cimino; Elisa De Luca; Wito Richter; Ruth Westenbroek; William A Catterall; Jin Zhang; Chen Yan; Marco Conti; Ana Maria Gomez; Grégoire Vandecasteele; Emilio Hirsch; Rodolphe Fischmeister
Journal:  Circulation       Date:  2012-09-24       Impact factor: 29.690

Review 10.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.